focus -WSS

focus

author：comprehensive 2025-09-27 09:54:31 - browse：66

Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research within the Food and Drug Administration, at a hearing — policy coverage from STAT — Peter Marks, director of the FDA's Center for Biologics Evaluation and Research Greg Nash/Pool via AP

WASHINGTON — A top Food and Drug Administration official wants Congress to dedicate full-time staff to emerging pathogens, after the FDA scrambled to find people for Covid-19 priorities like Operation Warp Speed.

“Vaccines were a pretty heavy duty lift during the pandemic,” said Peter Marks, director of the Center for Biologics Evaluation and Research, at a Thursday Politico event. “Rather than having to essentially reassign whole groups of people and disrupt things, the idea is to have a group of people who are constantly working on this.”

There is reason for optimism. Sens. John Hickenlooper (D-Colo.) and Ted Budd (R-N.C.) successfully added an amendment creating that team to a key pandemic preparedness bill that must be reauthorized by the end of September. It would establish this new program within Marks’ division of the FDA, staffed with experts on vaccines, antibodies, diagnostic tests, personal protective equipment, and other medical countermeasures. Among other activities, this team would enhance surveillance programs and prioritize vaccine research and development so that existing platforms can be retooled to fight other viruses.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： STAT Summit: The economic case for universal basic health care

WSS

Smaller biotechs seek to piggyback on weight loss drug boom

UnitedHealth, Optum discontinue NaviHealth name

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

Erich Jarvis studies song birds to learn about human stuttering

leisure time

focus

focus

Walensky prepares to leave CDC — and Congress — behind

Roivant's CEO is a star, but biotech's black hole persists

Heart attack and stroke risk calculators need revising

FDA clears Verve to begin U.S. study of gene

Hollywood unions extend contract negotiations for actors

Biotech investment managers search for lucrative opportunities

Heart attack and stroke risk calculators need revising

FDA clears Verve to begin U.S. study of gene

Affirmative action in medical school literally saved lives

STAT Summit: Ending the crisis of Black deaths in the U.S.

Wikipedia

Readout LOUD podcast, live from the STAT Breakthrough Summit East

Roivant's CEO is a star, but biotech's black hole persists

Surgeons perform first xenotransplant using CRISPR'd pig kidney

STAT Summit: Meghan O’Rourke on making chronic illness visible

Results on Novartis prostate cancer therapy could expand its use

Is there really a nursing shortage in the U.S.?

focus

hotspot

leisure time

focus